Bioxytran, Inc.

About Bioxytran, Inc.

Bioxytran is a clinical stage pharmaceutical company focused on developing platform technologies in Glycovirology, Hypoxia, and Degenerative Diseases to eliminate viruses and prolong lifespan through carbohydrate drug design.

Products & Services

Glycovirology Platform:A novel glycan-based platform technology using carbohydrate drugs as entry inhibitors to target viruses directly and modulate the immune system.

Hypoxia and Degenerative Diseases Platform:An innovative platform of oxygen therapeutic treatments for hypoxic conditions and necrosis prevention, targeting conditions like brain stroke, wound healing, and trauma.

ProLectin Pipeline:A pipeline focused on specific drug candidates within the Glycovirology platform.

BXT Pipeline:A pipeline of anti-necrosis drugs designed to treat hypoxia by delivering nanoscale oxygen carriers to affected tissues.

ProLectin pipeline

BXT pipeline

ProLectin

BXT oxygen transport molecule

Specialties

Glycovirology Hypoxia Treatment Degenerative Diseases Carbohydrate Drug Design Oxygen Therapeutics Anti-Necrosis Drugs Oxygen therapeutics Hypoxia treatment Antiviral drugs Degenerative disease therapeutics

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Private Placement T: - FT: Private Placement	A: 1200000 MR: - FA: 1.2 million FAN: 1200000	D: 2026-03-18 FD: 2026-03-18	-
2	RT: Private Placement T: - FT: Private Placement	A: 1200000 MR: - FA: $1.2M FAN: 1200000	D: 2026-03-01 FD: 2026-03-01	-
3	RT: Stock Purchase Agreement T: - FT: Stock Purchase Agreement	A: 1600000 MR: - FA: $1,600,000 FAN: 1600000	D: 2025-01-22 FD: 2025-01-22	1 investors
4	RT: Equity T: - FT: Equity	A: 500000 MR: - FA: $500,000 FAN: 500000	D: 2023-06-12 FD: 2023-06-12	1 investors

Private Placement Latest

2026-03-18

$1.2M

Private Placement 2026-03-01

$1.2M

Stock Purchase Agreement 2025-01-22

$1.6M

View 3 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

No team data available

Team information is not yet available for this company

Recent News

Bioxytran, Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised